Key facts
- Notable investors include Delphinus Venture Capital, INCUBA.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for LevitaCare
- ·The full record, as it builds
Funding rounds
No funding rounds for LevitaCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LevitaCare
Developer of a pelvic-floor support medical device designed to provide postpartum support and compression to aid healing and help prevent pelvic complications in women after childbirth. The company's device is intended to assist new mothers and healthcare providers in managing recovery, reducing discomfort, and mitigating risks such as prolapse and incontinence, enabling hospitals, nursing homes, and rehabilitation facilities to assist patients with mobility limitations while reducing physical strain on caregivers and supporting safe transfer procedures.
- Sector
- Healthcare
- HQ
- Aarhus Nord, Denmark
- Founded
- 2025
- Employees
- 4
- Website
- levitacare.dk/
- Ownership
- Privately Held (backing)
LevitaCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LevitaCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LevitaCare in its N-PORT filings yet. We sweep new filings monthly.